Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2013 Mar 21;19(6):10.1016/j.bbmt.2013.03.001. doi: 10.1016/j.bbmt.2013.03.001

Table 4.

Cause of death according to initial DLI CD3 cell/kg dose Groups

Group A
N=49
Group B
N=41
Group C
N=55
GVHD 4 (8%) 3 (7%) 5 (9%)
Relapse/progressive disease 44 (90%) 30 (73%) 37 (67%)
Relapse/progressive disease and GVHD 0 3 (7%) 4 (7%)
Other cause death 0 3 (7%) 4 (7%)
Unknown cause of death 1 (2%) 2 (5%) 5 (9%)

P=0.32 (excluding unknown causes)